Summary
Organogenesis Inc. is the leading developer of regenerative medicine therapies. Over the past 25 years, Organogenesis Inc. has been the first to be approved by the FDA for a living human cell-based therapy. They pride themselves on their ability to easily produce and distribute their products world wide and on their standing as experts in cell-based therapy.
Apligraf is a bioengineered cell construct launched by Organogenesis Inc. in 2000. Apligraf has been approved by the FDA for bio-active wound healing treatments. Apligraf is applied directly to the wound by a physician.
Eligibility
Apligraf Patient Assistance Program , a patient assistance program provided by Organogenesis Inc., offers Apligraf at no cost for the first prescription to those who are eligible for the program. Eligibility is based off of the following requirements:
The medication must be sent to the physicians office.
What´s Next?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call Organogenesis Inc. program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
Other Tips
- If you have any questions please call the Organogenesis Inc. program directly.
- Fill out as much of the information on the enrollment form as possible. The more information you have pre-filled the easier the progrm is to enroll in.
- Write down the refill dates for your program and set a reminder here on PatientAssistance.com so that you don't run out of medication.
- Do not write messy on your forms as this will delay any response.
- Call and write thank you notes to AAI Pharma Inc. program. Without their help millions of people will be without medication.